Drug Database
Back to search

Finland· FI-REL-REL592

Surmontil

A trimipramine product containing trimipramine maleate, registered in Finland by sanofi-aventis Oy. The same ATC class is registered in 11 of our 19 countries.

ATC N06AA06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSurmontilATCN06AA06REGISTER NO.FI-REL-REL592PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about trimipramine maleateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Trimipramine is registered in 11 of 19 countries.

Countries holding a registration under ATC N06AA06 (trimipramine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 6 of them publish a price we can compare per daily dose
Search trimipramine products by name

Trimipramine · ATC N06AA06

11 / 19 countries

  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trimipramine costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Trimipramine · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Trimipramine maleate
Manufacturer
sanofi-aventis Oy
Country
Finland (FI)
ATC code
N06AA06
ATC class
Trimipramine
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

406 interactions on record for trimipramine.

Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check trimipramine against other medicinesHow interaction checks work

Trimipramine · interactions on record

406 records

  • 64 severe
  • 225 moderate
  • 16 minor
  • 19 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

82 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trimipramine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trimipramine products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Germany · Stangyl, Stangyl Tabs
  • Spain · Surmontil
  • France · Surmontil
  • United Kingdom (Northern Ireland) · Trimipramine Focus Pharmaceuticals, Trimipramine Glenmark Pharmaceuticals Europe
  • Ireland · Surmontil
  • Italy · Surmontil
  • Norway · Surmontil
  • Portugal · Surmontil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/24f7d789-fbed-4d96-894f-05b10804e080
GET /v1/drugs/24f7d789-fbed-4d96-894f-05b10804e080?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.15",
  "form": "tabletti, kalvopäällysteinen",
  "route": null,
  "ddd_unit": "g",
  "strength": "50 mg",
  "atc_label": "trimipramiini",
  "ma_number": "5200",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL592",
  "authorised_at": "1968-01-17"
}
API referenceMCP serverPlans

See everything about trimipramine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console